Prognostic determinants for long term outcome of low grade follicular lymphomas after cytoreductive chemotherapy and interferon alpha maintenance. Results of the German Low Grade Lymphoma Study Group (GLSG).

被引：0
|
作者：
Unterhalt, M [1 ]
Hermann, R [1 ]
Koch, P [1 ]
Trumper, L [1 ]
Bodenstein, H [1 ]
Dietzfelbinger, H [1 ]
Landys, K [1 ]
Reuss, M [1 ]
Vetter, H [1 ]
Maschmeyer, G [1 ]
Freund, M [1 ]
Neubauer, A [1 ]
Engert, A [1 ]
Stauder, R [1 ]
Herold, M [1 ]
Tiemann, M [1 ]
Parwaresch, R [1 ]
Stein, H [1 ]
Hiddemann, W [1 ]
机构：
[1] UNIV GOTTINGEN,DEPT HEMATOL ONCOL,D-37075 GOTTINGEN,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1743 / 1743
页数：1
相关论文
共 50 条
  • [41] Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas -: results of a randomized comparison by the German Low-Grade Lymphoma Study Group
    Nickenig, C.
    Dreyling, M.
    Hoster, E.
    Ludwig, W. -D.
    Doerken, B.
    Freund, M.
    Huber, C.
    Ganser, A.
    Truemper, L.
    Forstpointner, R.
    Unterhalt, M.
    Hiddemann, W.
    ANNALS OF ONCOLOGY, 2007, 18 (01) : 136 - 142
  • [42] High anti-lymphoma activity of Bendamustine/Mitoxantrone/Rituximab (BMR) in rituximab pretreated relapsed or refractory indolent lymphomas. A multicentre phase II study of the german low grade lymphoma study group (GLSG).
    Weide, Rudolf
    Hess, Georg
    Koeppler, Hubert
    Heymanns, Jochen
    Thomalla, Joerg
    Aldaoud, Ali
    Losem, Christoph
    Schmitz, Stefan
    Haak, Ursula
    Huber, Christoph
    Unterhalt, Michael
    Hiddemann, Wolfgang
    Dreyling, Martin
    BLOOD, 2006, 108 (11) : 702A - 703A
  • [43] Front - Line combined immuno-chemotherapy (R-CHOP) significantly improves the time to treatment failure and overall survival in elderly patients with advanced stage follicular lymphoma - Results of a prospective randomized trial of the German low grade lymphoma study group (GLSG).
    Buske, Christian
    Kneba, Michael
    Lengfelder, Eva
    Pfreundschuh, Michael
    Ludwig, Wolf-Dieter
    Graeven, Ullrich
    Hallek, Michael
    Dreyling, Martin
    Unterhalt, Michael
    Hiddemann, Wolfgang
    BLOOD, 2006, 108 (11) : 146A - 147A
  • [44] TREATMENT OF LOW-GRADE AND INTERMEDIATE-GRADE LYMPHOMA WITH INTENSIVE COMBINATION CHEMOTHERAPY RESULTS IN LONG-TERM, DISEASE-FREE SURVIVAL
    LICHT, JD
    BOSSERMAN, LD
    ANDERSEN, JW
    YEAP, BY
    KLATT, MM
    MARTEL, JK
    ANDERSON, KC
    ROSENTHAL, DS
    PINKUS, G
    SKARIN, AT
    CANELLOS, GP
    CANCER, 1990, 66 (04) : 632 - 639
  • [45] Long-term outcome of gastric low-grade malt-lymphomas after eradication of H-pylori
    Mantzaris, GJ
    Rontogianni, D
    Petraki, K
    Archavlis, E
    Triantaphyllou, G
    GUT, 2001, 49 : A58 - A59
  • [46] The addition of rituximab to combination chemotherapy with fludarabine, cyclophosphamide, mitoxantrone (FCM) results in a significant increase of overall response as compared to FCM alone in patients with relapsed or refractory follicular (FCL) and mantel cell lymphomas (MCL) -: Results of a prospective randomized comparison of the German low grade study group (GLSG).
    Hiddemann, W
    Forstpointner, R
    Fiedler, F
    Gramatzki, M
    Dörken, B
    Illiger, HJ
    Kneba, M
    Pfreundschuh, M
    Parsold, R
    Parwaresch, R
    Dreyling, M
    Unterhalt, M
    BLOOD, 2001, 98 (11) : 844A - 844A
  • [47] Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas:: Results of a prospective comparative analysis of the German low-grade lymphoma study group
    Hiddemann, W
    Unterhalt, M
    Hermann, R
    Wöltjen, HH
    Kreuser, ED
    Trümper, L
    Reuss-Borst, M
    Terhardt-Kasten, E
    Busch, M
    Neubauer, A
    Kaiser, U
    Hanrath, RD
    Middeke, H
    Helm, G
    Freund, M
    Stein, H
    Tiemann, M
    Parwaresch, R
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1922 - 1930
  • [48] Long-term outcome of low-grade gastric MALT lymphoma after Helicobacter pylori eradication:: A prospective single center study
    Choi, You Sik
    Cheon, Jae Hee
    Lee, Jong-Yeol
    Ye, Byung Duk
    Kim, Sang Gyun
    Kim, Joo Sung
    Lung, Hyun Chae
    Song, In Sung
    GASTROENTEROLOGY, 2006, 130 (04) : A421 - A421
  • [49] FLUDARABINE SINGLE-AGENT THERAPY FOR RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II STUDY OF THE GERMAN LOW-GRADE NON-HODGKINS-LYMPHOMA STUDY-GROUP
    HIDDEMANN, W
    UNTERHALT, M
    POTT, C
    WORMANN, B
    SANDFORD, D
    FREUND, M
    ENGERT, A
    GASSMANN, W
    HOLTKAMP, W
    SEUFERT, J
    HELLRIEGEL, KP
    KNAUF, W
    EMMERICH, B
    KANZ, L
    KOCH, P
    SEMINARS IN ONCOLOGY, 1993, 20 (05) : 28 - 31
  • [50] Long-term outcome after first relapse for patients who received primary radiation therapy at Stanford University for stage I and II low grade follicular lymphomas.
    MacManus, MP
    Rainer, BCA
    Hoppe, RT
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 323 - 323
12345